The vaccine manufacturers in India, Dr Reddy's, have already submitted the safety and immunogenicity data of the third phase trialsDr Reddy’s had entered into a partnership with the Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik VDr Reddy's had applied for emergency approval for Sputnik V.
The company had conducted Phase 2 trials in India with around 1,500 participants. Phase 3 trials are still underway."We expect to get the approval in the next few weeks.
It is a two-dose vaccine. You take the first dose on day zero and the second one on day 21. The peak immunity develops somewhere between day 28 to day 42.
Read more on livemint.com